Narayana Hrudayalaya’s record shows a business that converts profit into cash at a high rate, with operating cash flow exceeding profit in each of the last five years. Two things dominate the picture: an ₹11,814 crore goodwill addition from a UK acquisition that now sits on the balance sheet, and a recurring audit-trail exception that has persisted across three fiscal years and expanded in scope. A cluster of contingent tax disputes, a rising capital-commitment pipeline, and a promoter family with three board seats and sharply escalating pay round out the governance picture.
Key findings
- An ₹11,814 crore goodwill addition from a UK acquisition now dominates the balance sheet
Major- Narayana Hrudayalaya UK Ltd acquired Practice Plus Group Hospitals Limited for GBP 18.88 crore in FY26, generating goodwill of ₹11,813.79 crore attributed to workforce and expected synergies. Management warns that an increase in the discount rate or a decrease in growth rates could trigger impairment in future periods. The auditor has repeatedly flagged impairment risk in subsidiaries as a Key Audit Matter in FY23, FY22, and FY20. - A recurring audit-trail exception has persisted across three fiscal years and expanded in scope
Major- The FY2026 standalone auditor’s report states that one accounting software does not capture corresponding previous values at the database level, and that the audit trail is preserved for only 180 days. In FY2024, the auditor reported that the audit trail feature was not enabled at the database level for two accounting softwares. The consolidated report for FY2026 extends the exception to the Parent and eight subsidiaries. - A GST penalty of ₹2.22 crore was levied for COVID vaccination services and disclosed late
Minor- The GST Authority issued an Order-in-Original dated 14 March 2025 demanding GST with a penalty of Rs. 2,21,63,065. The company disclosed the order intimation late, stating it was “inadvertently missed”. The Karnataka High Court passed an interim order staying the GST order, and the matter is sub-judice. - Two subsidiaries, one associate, one joint venture, and one subsidiary of a joint venture were unaudited
Minor- The unaudited financial information includes two subsidiaries (including one step-down subsidiary) with total assets of ₹0.06 crore and nil revenues, plus one associate, one joint venture, and one subsidiary of a joint venture with a combined net loss of ₹5.58 crore for the year ended 31 March 2026. - Two NCLT schemes are in progress, a ₹50.95 crore exceptional charge was taken for new labour codes, and useful lives were revised
Minor- The Group recognised an exceptional item of ₹50.95 crore in FY2025-26 for increased gratuity and leave liabilities upon notification of four Labour Codes on 21 November 2025. Management revised the useful lives of certain items of Property, Plant and Equipment with effect from 1 April 2025, accounted for prospectively. Two Schemes of Arrangement have received NCLT-convened shareholder and creditor approval and await final NCLT order. - Revenue recognition is a recurring Key Audit Matter due to expected credit losses on trade receivables, while a service-concession arrangement imposes below-market pricing
Minor- The auditor identified expected credit loss allowance on trade receivables as a Key Audit Matter in FY2023-24, with a standalone allowance of ₹35.51 crore and a consolidated allowance of ₹66.61 crore. Consolidated trade receivables grew from ₹635.35 crore to ₹742.69 crore during FY2025-26. A service-concession arrangement with NRHM Assam, effective 16 August 2012 and running to 15 August 2042, requires not less than 50% of hospital beds to be charged at 1.85% below NABH rates. - Operating cash flow consistently exceeds profit, but rising dividends and a large committed capex pipeline are absorbing the surplus
Clean- Consolidated CFO exceeded PAT in each of the last five fiscal years, from 1.42x in FY22 to 2.01x in FY26. The Board recommended a final dividend of ₹4.50 per share for FY2025-26, a cash outflow of ₹91.96 crore, up from ₹4.00 per share in FY2023-24. Estimated capital commitments stood at ₹493.39 crore as at 31 March 2026, up from ₹150.75 crore the previous year.
What to watch
- NCLT scheme orders. Final NCLT order on the merger of Meridian Medical Research & Hospital Ltd., petition filed 23 January 2026, and on the demerger of clinical services from NH Integrated Care Private Limited, petition filed 8 April 2026, both expected in due course.
- Kolkata GST demand. Resolution of the ₹15.93 crore GST demand for FY2020-21, for which the company decided to file a writ petition; under process as at 31 March 2026.
- Karnataka and Rajasthan tax stays. Outcome of the writ petitions on the ₹4.43 crore GST demand on COVID vaccination and the ₹4.76 crore Rajasthan VAT order; both stayed by the respective High Courts and pending as at 31 March 2026.
- PPG Hospitals impairment test. Next annual impairment test results for the PPG Hospitals CGU, carrying goodwill of ₹11,813.79 crore, to be reported in the FY2026-27 Annual Report.
- AGM remuneration vote. Outcome of the shareholder vote at the 26th AGM, scheduled 14 August 2026, on proposed remuneration revisions for Dr. Devi Prasad Shetty (₹26.17 crore), Mr. Viren Prasad Shetty (₹6.61 crore), and Dr. Emmanuel Rupert (₹11.33 crore).
Bottom line: This is a cash-generative hospital business with a disclosed and audited record. The risk sits in two places: the ₹11,814 crore goodwill balance, which turns on assumptions management itself flags as sensitive, and a control environment where the audit trail has been incomplete for three years running. Watch the impairment test outcome and the NCLT scheme orders, and read the tax contingency note with the Kolkata demand in mind.